Report Detail

Service & Software Global 3D Printing Drug Formulation and Administration Market Growth (Status and Outlook) 2022-2028

  • RnM4495366
  • |
  • 18 November, 2022
  • |
  • Global
  • |
  • 88 Pages
  • |
  • LPI(LP Information)
  • |
  • Service & Software

The global market for 3D Printing Drug Formulation and Administration is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

The APAC 3D Printing Drug Formulation and Administration market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The United States 3D Printing Drug Formulation and Administration market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The Europe 3D Printing Drug Formulation and Administration market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The China 3D Printing Drug Formulation and Administration market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

Global key 3D Printing Drug Formulation and Administration players cover Aprecia Pharmaceuticals, Triastek, FabRx, Multiply Labs and Merck KgaA, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

Report Coverage
This latest report provides a deep insight into the global 3D Printing Drug Formulation and Administration market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.

This report aims to provide a comprehensive picture of the global 3D Printing Drug Formulation and Administration market, with both quantitative and qualitative data, to help readers understand how the 3D Printing Drug Formulation and Administration market scenario changed across the globe during the pandemic and Russia-Ukraine War.

The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.

Market Segmentation:
The study segments the 3D Printing Drug Formulation and Administration market and forecasts the market size by Type (MED, FDM and SSE), by Application (Drugs and Dietary Supplement.), and region (APAC, Americas, Europe, and Middle East & Africa).

Segmentation by type
MED
FDM
SSE
Other

Segmentation by application
Drugs
Dietary Supplement

Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Major companies covered
Aprecia Pharmaceuticals
Triastek
FabRx
Multiply Labs
Merck KgaA
GlaxoSmithKline
Pfizer
Craft Health

Chapter Introduction
Chapter 1: Scope of 3D Printing Drug Formulation and Administration, Research Methodology, etc.
Chapter 2: Executive Summary, global 3D Printing Drug Formulation and Administration market size and CAGR, 3D Printing Drug Formulation and Administration market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: 3D Printing Drug Formulation and Administration revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global 3D Printing Drug Formulation and Administration revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global 3D Printing Drug Formulation and Administration market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including Aprecia Pharmaceuticals, Triastek, FabRx, Multiply Labs, Merck KgaA, GlaxoSmithKline, Pfizer and Craft Health, etc.
Chapter 14: Research Findings and Conclusion


1 Scope of the Report

  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered

2 Executive Summary

  • 2.1 World Market Overview
    • 2.1.1 Global 3D Printing Drug Formulation and Administration Market Size 2017-2028
    • 2.1.2 3D Printing Drug Formulation and Administration Market Size CAGR by Region 2017 VS 2022 VS 2028
  • 2.2 3D Printing Drug Formulation and Administration Segment by Type
    • 2.2.1 MED
    • 2.2.2 FDM
    • 2.2.3 SSE
    • 2.2.4 Other
  • 2.3 3D Printing Drug Formulation and Administration Market Size by Type
    • 2.3.1 3D Printing Drug Formulation and Administration Market Size CAGR by Type (2017 VS 2022 VS 2028)
    • 2.3.2 Global 3D Printing Drug Formulation and Administration Market Size Market Share by Type (2017-2022)
  • 2.4 3D Printing Drug Formulation and Administration Segment by Application
    • 2.4.1 Drugs
    • 2.4.2 Dietary Supplement
  • 2.5 3D Printing Drug Formulation and Administration Market Size by Application
    • 2.5.1 3D Printing Drug Formulation and Administration Market Size CAGR by Application (2017 VS 2022 VS 2028)
    • 2.5.2 Global 3D Printing Drug Formulation and Administration Market Size Market Share by Application (2017-2022)

3 3D Printing Drug Formulation and Administration Market Size by Player

  • 3.1 3D Printing Drug Formulation and Administration Market Size Market Share by Players
    • 3.1.1 Global 3D Printing Drug Formulation and Administration Revenue by Players (2020-2022)
    • 3.1.2 Global 3D Printing Drug Formulation and Administration Revenue Market Share by Players (2020-2022)
  • 3.2 Global 3D Printing Drug Formulation and Administration Key Players Head office and Products Offered
  • 3.3 Market Concentration Rate Analysis
    • 3.3.1 Competition Landscape Analysis
    • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
  • 3.4 New Products and Potential Entrants
  • 3.5 Mergers & Acquisitions, Expansion

4 3D Printing Drug Formulation and Administration by Regions

  • 4.1 3D Printing Drug Formulation and Administration Market Size by Regions (2017-2022)
  • 4.2 Americas 3D Printing Drug Formulation and Administration Market Size Growth (2017-2022)
  • 4.3 APAC 3D Printing Drug Formulation and Administration Market Size Growth (2017-2022)
  • 4.4 Europe 3D Printing Drug Formulation and Administration Market Size Growth (2017-2022)
  • 4.5 Middle East & Africa 3D Printing Drug Formulation and Administration Market Size Growth (2017-2022)

5 Americas

  • 5.1 Americas 3D Printing Drug Formulation and Administration Market Size by Country (2017-2022)
  • 5.2 Americas 3D Printing Drug Formulation and Administration Market Size by Type (2017-2022)
  • 5.3 Americas 3D Printing Drug Formulation and Administration Market Size by Application (2017-2022)
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil

6 APAC

  • 6.1 APAC 3D Printing Drug Formulation and Administration Market Size by Region (2017-2022)
  • 6.2 APAC 3D Printing Drug Formulation and Administration Market Size by Type (2017-2022)
  • 6.3 APAC 3D Printing Drug Formulation and Administration Market Size by Application (2017-2022)
  • 6.4 China
  • 6.5 Japan
  • 6.6 Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia

7 Europe

  • 7.1 Europe 3D Printing Drug Formulation and Administration by Country (2017-2022)
  • 7.2 Europe 3D Printing Drug Formulation and Administration Market Size by Type (2017-2022)
  • 7.3 Europe 3D Printing Drug Formulation and Administration Market Size by Application (2017-2022)
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia

8 Middle East & Africa

  • 8.1 Middle East & Africa 3D Printing Drug Formulation and Administration by Region (2017-2022)
  • 8.2 Middle East & Africa 3D Printing Drug Formulation and Administration Market Size by Type (2017-2022)
  • 8.3 Middle East & Africa 3D Printing Drug Formulation and Administration Market Size by Application (2017-2022)
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities
  • 9.2 Market Challenges & Risks
  • 9.3 Industry Trends

10 Global 3D Printing Drug Formulation and Administration Market Forecast

  • 10.1 Global 3D Printing Drug Formulation and Administration Forecast by Regions (2023-2028)
    • 10.1.1 Global 3D Printing Drug Formulation and Administration Forecast by Regions (2023-2028)
    • 10.1.2 Americas 3D Printing Drug Formulation and Administration Forecast
    • 10.1.3 APAC 3D Printing Drug Formulation and Administration Forecast
    • 10.1.4 Europe 3D Printing Drug Formulation and Administration Forecast
    • 10.1.5 Middle East & Africa 3D Printing Drug Formulation and Administration Forecast
  • 10.2 Americas 3D Printing Drug Formulation and Administration Forecast by Country (2023-2028)
    • 10.2.1 United States 3D Printing Drug Formulation and Administration Market Forecast
    • 10.2.2 Canada 3D Printing Drug Formulation and Administration Market Forecast
    • 10.2.3 Mexico 3D Printing Drug Formulation and Administration Market Forecast
    • 10.2.4 Brazil 3D Printing Drug Formulation and Administration Market Forecast
  • 10.3 APAC 3D Printing Drug Formulation and Administration Forecast by Region (2023-2028)
    • 10.3.1 China 3D Printing Drug Formulation and Administration Market Forecast
    • 10.3.2 Japan 3D Printing Drug Formulation and Administration Market Forecast
    • 10.3.3 Korea 3D Printing Drug Formulation and Administration Market Forecast
    • 10.3.4 Southeast Asia 3D Printing Drug Formulation and Administration Market Forecast
    • 10.3.5 India 3D Printing Drug Formulation and Administration Market Forecast
    • 10.3.6 Australia 3D Printing Drug Formulation and Administration Market Forecast
  • 10.4 Europe 3D Printing Drug Formulation and Administration Forecast by Country (2023-2028)
    • 10.4.1 Germany 3D Printing Drug Formulation and Administration Market Forecast
    • 10.4.2 France 3D Printing Drug Formulation and Administration Market Forecast
    • 10.4.3 UK 3D Printing Drug Formulation and Administration Market Forecast
    • 10.4.4 Italy 3D Printing Drug Formulation and Administration Market Forecast
    • 10.4.5 Russia 3D Printing Drug Formulation and Administration Market Forecast
  • 10.5 Middle East & Africa 3D Printing Drug Formulation and Administration Forecast by Region (2023-2028)
    • 10.5.1 Egypt 3D Printing Drug Formulation and Administration Market Forecast
    • 10.5.2 South Africa 3D Printing Drug Formulation and Administration Market Forecast
    • 10.5.3 Israel 3D Printing Drug Formulation and Administration Market Forecast
    • 10.5.4 Turkey 3D Printing Drug Formulation and Administration Market Forecast
    • 10.5.5 GCC Countries 3D Printing Drug Formulation and Administration Market Forecast
  • 10.6 Global 3D Printing Drug Formulation and Administration Forecast by Type (2023-2028)
  • 10.7 Global 3D Printing Drug Formulation and Administration Forecast by Application (2023-2028)

11 Key Players Analysis

  • 11.1 Aprecia Pharmaceuticals
    • 11.1.1 Aprecia Pharmaceuticals Company Information
    • 11.1.2 Aprecia Pharmaceuticals 3D Printing Drug Formulation and Administration Product Offered
    • 11.1.3 Aprecia Pharmaceuticals 3D Printing Drug Formulation and Administration Revenue, Gross Margin and Market Share (2020-2022)
    • 11.1.4 Aprecia Pharmaceuticals Main Business Overview
    • 11.1.5 Aprecia Pharmaceuticals Latest Developments
  • 11.2 Triastek
    • 11.2.1 Triastek Company Information
    • 11.2.2 Triastek 3D Printing Drug Formulation and Administration Product Offered
    • 11.2.3 Triastek 3D Printing Drug Formulation and Administration Revenue, Gross Margin and Market Share (2020-2022)
    • 11.2.4 Triastek Main Business Overview
    • 11.2.5 Triastek Latest Developments
  • 11.3 FabRx
    • 11.3.1 FabRx Company Information
    • 11.3.2 FabRx 3D Printing Drug Formulation and Administration Product Offered
    • 11.3.3 FabRx 3D Printing Drug Formulation and Administration Revenue, Gross Margin and Market Share (2020-2022)
    • 11.3.4 FabRx Main Business Overview
    • 11.3.5 FabRx Latest Developments
  • 11.4 Multiply Labs
    • 11.4.1 Multiply Labs Company Information
    • 11.4.2 Multiply Labs 3D Printing Drug Formulation and Administration Product Offered
    • 11.4.3 Multiply Labs 3D Printing Drug Formulation and Administration Revenue, Gross Margin and Market Share (2020-2022)
    • 11.4.4 Multiply Labs Main Business Overview
    • 11.4.5 Multiply Labs Latest Developments
  • 11.5 Merck KgaA
    • 11.5.1 Merck KgaA Company Information
    • 11.5.2 Merck KgaA 3D Printing Drug Formulation and Administration Product Offered
    • 11.5.3 Merck KgaA 3D Printing Drug Formulation and Administration Revenue, Gross Margin and Market Share (2020-2022)
    • 11.5.4 Merck KgaA Main Business Overview
    • 11.5.5 Merck KgaA Latest Developments
  • 11.6 GlaxoSmithKline
    • 11.6.1 GlaxoSmithKline Company Information
    • 11.6.2 GlaxoSmithKline 3D Printing Drug Formulation and Administration Product Offered
    • 11.6.3 GlaxoSmithKline 3D Printing Drug Formulation and Administration Revenue, Gross Margin and Market Share (2020-2022)
    • 11.6.4 GlaxoSmithKline Main Business Overview
    • 11.6.5 GlaxoSmithKline Latest Developments
  • 11.7 Pfizer
    • 11.7.1 Pfizer Company Information
    • 11.7.2 Pfizer 3D Printing Drug Formulation and Administration Product Offered
    • 11.7.3 Pfizer 3D Printing Drug Formulation and Administration Revenue, Gross Margin and Market Share (2020-2022)
    • 11.7.4 Pfizer Main Business Overview
    • 11.7.5 Pfizer Latest Developments
  • 11.8 Craft Health
    • 11.8.1 Craft Health Company Information
    • 11.8.2 Craft Health 3D Printing Drug Formulation and Administration Product Offered
    • 11.8.3 Craft Health 3D Printing Drug Formulation and Administration Revenue, Gross Margin and Market Share (2020-2022)
    • 11.8.4 Craft Health Main Business Overview
    • 11.8.5 Craft Health Latest Developments

12 Research Findings and Conclusion

Summary:
Get latest Market Research Reports on 3D Printing Drug Formulation and Administration. Industry analysis & Market Report on 3D Printing Drug Formulation and Administration is a syndicated market report, published as Global 3D Printing Drug Formulation and Administration Market Growth (Status and Outlook) 2022-2028. It is complete Research Study and Industry Analysis of 3D Printing Drug Formulation and Administration market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

Last updated on

REPORT YOU MIGHT BE INTERESTED

Purchase this Report

$3,660.00
$7,320.00
3,034.14
6,068.28
3,524.58
7,049.16
510,350.40
1,020,700.80
298,619.40
597,238.80
Credit card Logo

Related Reports


Reason to Buy

Request for Sample of this report